Skip to main content
Top
Published in: BMC Neurology 1/2022

Open Access 01-12-2022 | Status Epilepticus | Research

Timing matters: there are significant differences in short-term outcomes between two time points of status epilepticus

Authors: Yiwen Pan, Yu Feng, Weifeng Peng, Yang Cai, Jing Ding, Xin Wang

Published in: BMC Neurology | Issue 1/2022

Login to get access

Abstract

Background

In 2015, the International League Against Epilepsy proposed a new conceptual definition of status epilepticus (SE) with two operational dimensions (t1 and t2) to guide emergency treatment. The purpose of this study was to compare clinical characteristics and prognoses of patients at these two different time points.

Methods

We conducted a prospective observational cohort study of consecutive adults diagnosed with SE. In case of convulsive SE, t1 is 5 min and t2 is 30 min, whereas in case of focal SE with impaired consciousness, t1 is 10 min, t2 is 60 min. Data on clinical characteristics, including age, gender, history of prior seizures, neuroimaging, semiology, duration, and etiology of SE, were collected. The primary outcome was mortality, with seizure recurrence as a secondary measure, and functional status as tertiary outcome of enrolled patients at 3 months after SE onset.

Results

We screened one hundred patients with SE, with a median age of 66 years and 61% were male. Fifty-six (56.0%) patients reached t1 of SE, while 44 (44.0%) reached t2 of SE. Convulsive SE (52.0%, n = 52) was more common than focal SE with impaired consciousness (48.0%, n = 48). Status epilepticus secondary to an acute symptomatic process was the most common (50%, n = 50). Patients meeting t2 of SE demonstrated a remarkably increased risk of mortality (unadjusted analysis-RR 3.606, 95%CI 1.552–8.376, p = 0.003; adjusted analysis-RR 2.924, 95%CI 1.221–7.003, p = 0.016) and unfavorable functional status (unadjusted analysis-RR 1.803, 95%CI 1.280–2.539, p = 0.001; adjusted analysis-RR 1.664, 95%CI 1.184–2.340, p = 0.003) at 3 months compared to those who only reached t1 of SE. Patients reaching t2 of SE were more likely to experience seizure recurrence, however, there was no significant difference between the two cohorts.

Conclusions

Our study provides strong support for the new definition of SE. Patients meeting t2 of SE tend to have a remarkably increased risk of mortality and unfavorable functional outcomes compared to those who only reached t1 of SE. Furthermore, patients were likely to experience seizure recurrence after undergoing an episode of SE. Physicians must be educated about prompt recognition and appropriate management of SE.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Rosenow F, Hamer HM, Knake S. The epidemiology of convulsive and nonconvulsive status epilepticus. Epilepsia. 2007;48(Suppl 8):82–4.PubMedCrossRef Rosenow F, Hamer HM, Knake S. The epidemiology of convulsive and nonconvulsive status epilepticus. Epilepsia. 2007;48(Suppl 8):82–4.PubMedCrossRef
3.
go back to reference Kantanen AM, Reinikainen M, Parviainen I, Ruokonend E, Ala-Peijari M, Bäcklundetal T, et al. Incidence and mortality of super-refractory status epilepticus in adults. Epilepsy Behav. 2015;49:131–4.PubMedCrossRef Kantanen AM, Reinikainen M, Parviainen I, Ruokonend E, Ala-Peijari M, Bäcklundetal T, et al. Incidence and mortality of super-refractory status epilepticus in adults. Epilepsy Behav. 2015;49:131–4.PubMedCrossRef
4.
go back to reference Chin RF, Neville BG, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol. 2004;11:800–10.PubMedCrossRef Chin RF, Neville BG, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol. 2004;11:800–10.PubMedCrossRef
5.
go back to reference Logroscino G, Hesdorffer DC, Cascino G, Allen Hauser W, Coeytaux A, Galobardes B, et al. Mortality after a first episode of status epilepticus in the United States and Europe. Epilepsia. 2005;46(Suppl 11):46–8.PubMedCrossRef Logroscino G, Hesdorffer DC, Cascino G, Allen Hauser W, Coeytaux A, Galobardes B, et al. Mortality after a first episode of status epilepticus in the United States and Europe. Epilepsia. 2005;46(Suppl 11):46–8.PubMedCrossRef
6.
go back to reference Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia. 1994;35:27–34.PubMedCrossRef Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia. 1994;35:27–34.PubMedCrossRef
7.
go back to reference Sutter R, Kaplan PW, Rüegg S. Outcome predictors for status epilepticus—what really counts. Nat Rev Neurol. 2013;9:525–34.PubMedCrossRef Sutter R, Kaplan PW, Rüegg S. Outcome predictors for status epilepticus—what really counts. Nat Rev Neurol. 2013;9:525–34.PubMedCrossRef
8.
go back to reference DeLorenzo RJ, Garnett LK, Towne AR, Waterhouse EJ, Boggs JG, Morton L, et al. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia. 1999;40:164–9.PubMedCrossRef DeLorenzo RJ, Garnett LK, Towne AR, Waterhouse EJ, Boggs JG, Morton L, et al. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia. 1999;40:164–9.PubMedCrossRef
9.
go back to reference Bone RC. Recommendations of the Epilepsy Foundation of America’s Working Group on Status Epilepticus. Treatment of convulsive status epilepticus. JAMA. 1993;270:854–49. Bone RC. Recommendations of the Epilepsy Foundation of America’s Working Group on Status Epilepticus. Treatment of convulsive status epilepticus. JAMA. 1993;270:854–49.
10.
go back to reference Commission on Epidemiology and Prognosis, International League Against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia. 1993;34:592–6. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia. 1993;34:592–6.
11.
go back to reference Lowenstein DH, Bleck T, MacDonald RL. It’s time to revise the definition of status epilepticus. Epilepsia. 1999;40:120–2.PubMedCrossRef Lowenstein DH, Bleck T, MacDonald RL. It’s time to revise the definition of status epilepticus. Epilepsia. 1999;40:120–2.PubMedCrossRef
12.
go back to reference Shinnar S, Berg AT, Moshe SL, Shinnar R. How long do new-onset seizures in children last. Ann Neurol. 2001;49:659–64.PubMedCrossRef Shinnar S, Berg AT, Moshe SL, Shinnar R. How long do new-onset seizures in children last. Ann Neurol. 2001;49:659–64.PubMedCrossRef
13.
go back to reference Jenssen S, Gracely EJ, Sperling MR. How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit. Epilepsia. 2006;47:1499–503.PubMedCrossRef Jenssen S, Gracely EJ, Sperling MR. How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit. Epilepsia. 2006;47:1499–503.PubMedCrossRef
14.
go back to reference Dobesberger J, Ristic AJ, Walser G, Kuchukhidze G, Unterberger I, Höfler J, et al. Duration of focal complex, secondarily generalized tonic-clonic, and primarily generalized tonic-clonic seizures: a video-EEG analysis. Epilepsy Behav. 2015;49:111–7.PubMedCrossRef Dobesberger J, Ristic AJ, Walser G, Kuchukhidze G, Unterberger I, Höfler J, et al. Duration of focal complex, secondarily generalized tonic-clonic, and primarily generalized tonic-clonic seizures: a video-EEG analysis. Epilepsy Behav. 2015;49:111–7.PubMedCrossRef
15.
go back to reference Jones DM, Esmaeil N, Maren S, Macdonald RL. Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus. Epilepsy Res. 2002;50:301–12.PubMedCrossRef Jones DM, Esmaeil N, Maren S, Macdonald RL. Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus. Epilepsy Res. 2002;50:301–12.PubMedCrossRef
16.
go back to reference Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus–Report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56:1515–23.PubMedCrossRef Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus–Report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56:1515–23.PubMedCrossRef
17.
go back to reference Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3–23.PubMedCrossRef Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3–23.PubMedCrossRef
18.
go back to reference Kapur J, Elm J, Chamberlain JM, Barsan W, Cloyd J, Lowenstein D, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;12:2104–13. Kapur J, Elm J, Chamberlain JM, Barsan W, Cloyd J, Lowenstein D, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;12:2104–13.
19.
go back to reference Leitinger M, Holler Y, Kalss G, Rohracher A, Novak HF, Hofler J, et al. Epidemiology-based mortality score in status epilepticus (EMSE). Neurocrit Care. 2015;22:273–82.PubMedCrossRef Leitinger M, Holler Y, Kalss G, Rohracher A, Novak HF, Hofler J, et al. Epidemiology-based mortality score in status epilepticus (EMSE). Neurocrit Care. 2015;22:273–82.PubMedCrossRef
20.
go back to reference Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB. Prognosis of status epilepticus: role of etiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry. 2006;77:611–5.PubMedPubMedCentralCrossRef Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB. Prognosis of status epilepticus: role of etiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry. 2006;77:611–5.PubMedPubMedCentralCrossRef
21.
go back to reference Qiong G, Tang-peng OY, Xiao-long S, Feng Y, Chen W, Tao K, et al. Prediction of functional outcome in patients with convulsive status epilepticus: the END-IT score. Crit Care. 2016;20:46.CrossRef Qiong G, Tang-peng OY, Xiao-long S, Feng Y, Chen W, Tao K, et al. Prediction of functional outcome in patients with convulsive status epilepticus: the END-IT score. Crit Care. 2016;20:46.CrossRef
22.
go back to reference Hirsch LJ, Fong MWK, Leitinger M, LaRoche SM, Beniczky S, Abend NS, et al. American clinical neurophysiology society’s standardized critical care EEG terminology: 2021 Version. J Clin Neurophysiol. 2021;38:1–29.PubMedPubMedCentralCrossRef Hirsch LJ, Fong MWK, Leitinger M, LaRoche SM, Beniczky S, Abend NS, et al. American clinical neurophysiology society’s standardized critical care EEG terminology: 2021 Version. J Clin Neurophysiol. 2021;38:1–29.PubMedPubMedCentralCrossRef
23.
go back to reference Beniczky S, Hirsch LJ, Kaplan PW, Pressler R, Bauer G, Aurlien H, et al. Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia. 2013;54(Suppl 6):28–9.PubMedCrossRef Beniczky S, Hirsch LJ, Kaplan PW, Pressler R, Bauer G, Aurlien H, et al. Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia. 2013;54(Suppl 6):28–9.PubMedCrossRef
24.
go back to reference Leitinger M, Beniczky S, Rohracher A, Gardella E, Kalss G, Qerama E, et al. Salzburg consensus criteria for non-convulsive status epilepticus–approach to clinical application. Epilepsy Behav. 2015;49:158–63.PubMedCrossRef Leitinger M, Beniczky S, Rohracher A, Gardella E, Kalss G, Qerama E, et al. Salzburg consensus criteria for non-convulsive status epilepticus–approach to clinical application. Epilepsy Behav. 2015;49:158–63.PubMedCrossRef
25.
go back to reference van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–7.PubMedCrossRef van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–7.PubMedCrossRef
26.
go back to reference Zou JY. A Modified Poisson Regression Approach to Prospective Studies with Binary Data. Am J Epidemiol. 2004;159(7):702–6.PubMedCrossRef Zou JY. A Modified Poisson Regression Approach to Prospective Studies with Binary Data. Am J Epidemiol. 2004;159(7):702–6.PubMedCrossRef
27.
go back to reference Beghi E, Carpi A, Forsgren L, Hesdorffer DC, Malmgren K, Sander JW, et al. Recommendations for a definition of acute symptomatic seizure. Epilepsia. 2010;51(4):671–5.PubMedCrossRef Beghi E, Carpi A, Forsgren L, Hesdorffer DC, Malmgren K, Sander JW, et al. Recommendations for a definition of acute symptomatic seizure. Epilepsia. 2010;51(4):671–5.PubMedCrossRef
28.
go back to reference Rui-Juan L, Qun W, Tao C, Fei Z, Xiao-Qiu S. Status epilepticus related etiology, incidence and mortality: a meta-analysis. Epilepsy Res. 2017;136:12–7.CrossRef Rui-Juan L, Qun W, Tao C, Fei Z, Xiao-Qiu S. Status epilepticus related etiology, incidence and mortality: a meta-analysis. Epilepsy Res. 2017;136:12–7.CrossRef
29.
go back to reference Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Incidence of status epilepticus in Rochester, Minnesota, 1965–1984. Neurology. 1988;50:735–41.CrossRef Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Incidence of status epilepticus in Rochester, Minnesota, 1965–1984. Neurology. 1988;50:735–41.CrossRef
30.
go back to reference Coeytaux A, Jallon P, Galobardes B, Morabia A. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology. 2000;55:693–7.PubMedCrossRef Coeytaux A, Jallon P, Galobardes B, Morabia A. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology. 2000;55:693–7.PubMedCrossRef
31.
go back to reference Nelson SE, Varelas PN. Status epilepticus, refractory status epilepticus, and super-refractory status epilepticus. Neurocrit Care. 2018;24:1683–707. Nelson SE, Varelas PN. Status epilepticus, refractory status epilepticus, and super-refractory status epilepticus. Neurocrit Care. 2018;24:1683–707.
32.
go back to reference Wu YW, Shek DW, Garcia PA, Zhao S, Johnston SC. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology. 2002;58:1070–706.PubMedCrossRef Wu YW, Shek DW, Garcia PA, Zhao S, Johnston SC. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology. 2002;58:1070–706.PubMedCrossRef
33.
go back to reference Gaínza-Lein M, Fernández IS, Jackson M, Abend NS, Arya R, Brenton JN, et al. Association of Time to Treatment with Outcomes for Pediatric Patients with Status Epilepticus. JAMA Neurol. 2018;75:410–8.PubMedPubMedCentralCrossRef Gaínza-Lein M, Fernández IS, Jackson M, Abend NS, Arya R, Brenton JN, et al. Association of Time to Treatment with Outcomes for Pediatric Patients with Status Epilepticus. JAMA Neurol. 2018;75:410–8.PubMedPubMedCentralCrossRef
34.
go back to reference Fernández IS, Abend NS, Agadi S, An S, Arya R, Brenton JN, et al. Pediatric Status Epilepticus Research Group (pSERG). Time from convulsive status epilepticus onset to anticonvulsant administration in children. Neurology. 2015;84:2304–11.CrossRef Fernández IS, Abend NS, Agadi S, An S, Arya R, Brenton JN, et al. Pediatric Status Epilepticus Research Group (pSERG). Time from convulsive status epilepticus onset to anticonvulsant administration in children. Neurology. 2015;84:2304–11.CrossRef
35.
go back to reference Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann Neurol. 1998;44:908–12.PubMedCrossRef Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann Neurol. 1998;44:908–12.PubMedCrossRef
36.
go back to reference Leung H, Man CBL, Hui ACF, Kwan P, Wong KS. Prognosticating acute symptomatic seizures using two different seizure outcomes. Epilepsia. 2010;51:1570–9.PubMedCrossRef Leung H, Man CBL, Hui ACF, Kwan P, Wong KS. Prognosticating acute symptomatic seizures using two different seizure outcomes. Epilepsia. 2010;51:1570–9.PubMedCrossRef
37.
go back to reference Alvarez V, Westover MB, Drislane FW, Dworetzky BA, Curley D, Lee JW, et al. Evaluation of a clinical tool for early etiology identification in status epilepticus. Epilepsia. 2014;55:2059–68.PubMedPubMedCentralCrossRef Alvarez V, Westover MB, Drislane FW, Dworetzky BA, Curley D, Lee JW, et al. Evaluation of a clinical tool for early etiology identification in status epilepticus. Epilepsia. 2014;55:2059–68.PubMedPubMedCentralCrossRef
38.
go back to reference Rantsch K, Walter U, Wittstock M, Benecke R, Rosche J. Treatment and course of different subtypes of status epilepticus. Epilepsy Res. 2013;107:156–62.PubMedCrossRef Rantsch K, Walter U, Wittstock M, Benecke R, Rosche J. Treatment and course of different subtypes of status epilepticus. Epilepsy Res. 2013;107:156–62.PubMedCrossRef
39.
go back to reference Cheng JY. Latency to treatment of status epilepticus is associated with mortality and functional status. J Neurol Sci. 2016;370:290–5.PubMedCrossRef Cheng JY. Latency to treatment of status epilepticus is associated with mortality and functional status. J Neurol Sci. 2016;370:290–5.PubMedCrossRef
40.
go back to reference Rossetti AO, Alvarez V, Januel JM, Burnand B. Treatment deviating from guidelines does not influence status epilepticus prognosis. J Neurol. 2013;260:421–8.PubMedCrossRef Rossetti AO, Alvarez V, Januel JM, Burnand B. Treatment deviating from guidelines does not influence status epilepticus prognosis. J Neurol. 2013;260:421–8.PubMedCrossRef
41.
42.
go back to reference Gaínza-Leina M, Fernándeza IS, Ulate-Campos A, Loddenkemper T, Ostendorf AP. Timing in the treatment of status epilepticus: from basics to the clinic. Seizure. 2018;68:22–30.CrossRef Gaínza-Leina M, Fernándeza IS, Ulate-Campos A, Loddenkemper T, Ostendorf AP. Timing in the treatment of status epilepticus: from basics to the clinic. Seizure. 2018;68:22–30.CrossRef
43.
go back to reference Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American epilepsy society. Epilepsy Curr. 2016;16:48–61.PubMedPubMedCentralCrossRef Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American epilepsy society. Epilepsy Curr. 2016;16:48–61.PubMedPubMedCentralCrossRef
Metadata
Title
Timing matters: there are significant differences in short-term outcomes between two time points of status epilepticus
Authors
Yiwen Pan
Yu Feng
Weifeng Peng
Yang Cai
Jing Ding
Xin Wang
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-022-02868-y

Other articles of this Issue 1/2022

BMC Neurology 1/2022 Go to the issue